The Valley Desk

NCT00851734 · Interventional trial

A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)

Overall registry status Completed

Phase 1

Conditions Keratoconjunctivitis Sicca

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov